1. Ambrx, Inc. (27 from 113 patents)

2. Enanta Pharmaceuticals, Inc. (10 from 290 patents)

3. Concortis Biosystems, Corp. (4 from 4 patents)

4. Sorrento Therapeutics, Inc. (2 from 112 patents)

5. Other (1 from 832,680 patents)

6. Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. (1 from 26 patents)

7. Vivasor, Inc. (1 from 10 patents)

8. Concortis Biosystems, Corp., a Wholly Owned Subsidiary of Sorrento Therapeutics, Inc. (1 from 1 patent)

9. Abrx, Inc. (1 from 1 patent)

10. Amerx, Inc. (1 from 1 patent)

1. 12115228 - Drug-conjugates, conjugation methods, and uses thereof

2. 11987622 - Drug-conjugates with a targeting molecule and two different drugs

3. 11903948 - Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof

4. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

5. 10967071 - Drug-conjugates, conjugation methods, and uses thereof

6. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

7. 10836821 - Drug-conjugates with a targeting molecule and two different drugs

8. 10590165 - Antibody drug conjugates

9. 9981046 - Drug-conjugates, conjugation methods, and uses thereof

10. 9884127 - Drug-conjugates, conjugation methods, and uses thereof

11. 9801951 - Drug-conjugates, conjugation methods, and uses thereof

12. 9796754 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

13. 9637441 - Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

14. 9586988 - Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

15. 9488660 - Methods and compositions comprising non-natural amino acids